Vulnerable pregnant women should consider COVID-19 vaccine: RANZCOG
Pregnant women with significant comorbidities should consider vaccination against COVID-19 but there’s insufficient evidence to recommend it routinely, RANZCOG says.
The mRNA vaccine Comirnaty, approved by the TGA on Monday, has not been tested in pregnant women during phase 3 trials.
The TGA’s advice is that Pfizer’s vaccine “should only be considered when the potential benefits outweigh any potential risks for the mother and fetus”.
In a lengthy position statement, the obstetricians’ peak group says that, based on the low risk